These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21494045)

  • 1. Prediction of the outcome of inpatient opiate detoxification treatment: results from a multicenter study.
    Specka M; Buchholz A; Kuhlmann T; Rist F; Scherbaum N
    Eur Addict Res; 2011; 17(4):178-84. PubMed ID: 21494045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapse and relapse following inpatient treatment of opiate dependence.
    Smyth BP; Barry J; Keenan E; Ducray K
    Ir Med J; 2010 Jun; 103(6):176-9. PubMed ID: 20669601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
    J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit methadone use and abuse in young people accessing treatment for opiate dependence.
    Roche A; McCabe S; Smyth BP
    Eur Addict Res; 2008; 14(4):219-25. PubMed ID: 18679031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and hostility as predictors of long-term outcomes among opiate users.
    Rao SR; Broome KM; Simpson DD
    Addiction; 2004 May; 99(5):579-89. PubMed ID: 15078232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome predictors in flexible dose-duration methadone detoxification program.
    Ekhtiari H; Dezfouli A; Zamanian B; Ghodousi A; Mokri A
    Arch Iran Med; 2013 Oct; 16(10):599-601. PubMed ID: 24093142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored.
    Magura S; Rosenblum A
    Mt Sinai J Med; 2001 Jan; 68(1):62-74. PubMed ID: 11135508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid dependence as a chronic disease: the interrelationships between length of stay, methadone dose, and age on treatment outcome at an urban opioid treatment program.
    Kritz S; Chu M; John-Hull C; Madray C; Louie B; Brown LS
    J Addict Dis; 2009; 28(1):53-6. PubMed ID: 19197595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.